Lista de obras - Emmanouil Saloustros - Dominio Público Uruguay

A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

artículo científico publicado en 2020

A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

artículo científico publicado en 2018

Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families

article

Advanced non-small-cell lung cancer in the elderly.

artículo científico publicado en 2009

Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)

artículo científico publicado en 2016

Anti-CV2 associated cerebellar degeneration after complete response to chemoradiation of head and neck carcinoma

artículo científico publicado en 2009

Association analysis identifies 65 new breast cancer risk loci.

artículo científico publicado en 2017

Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

artículo científico publicado en 2021

Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis

article by Xiang Shu et al published 1 October 2018 in International Journal of Epidemiology

Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

artículo científico publicado en 2020

Candidate DNA repair susceptibility genes identified by exome sequencing in high-risk pancreatic cancer

artículo científico publicado en 2015

Care of adolescents and young adults with cancer in Asia: results of an ESMO/SIOPE/SIOP Asia survey

scientific article published on 06 June 2019

Case 17-2011: A Woman with a Mass in the Breast and Overlying Skin Changes

artículo científico publicado en 2011

Celecoxib reduces glucocorticoids in vitro and in a mouse model with adrenocortical hyperplasia

artículo científico publicado en 2015

Celecoxib treatment of fibrous dysplasia (FD) in a human FD cell line and FD-like lesions in mice with protein kinase A (PKA) defects

artículo científico publicado en 2016

Common variants in breast cancer risk loci predispose to distinct tumor subtypes

artículo científico publicado en 2022

Cytokeratin 19-positive circulating tumor cells in early breast cancer prognosis.

artículo científico publicado en 2010

Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse.

artículo científico publicado en 2011

Docetaxel in the treatment of advanced non-small-cell lung cancer.

scientific article published on August 2008

Dose-dense paclitaxel versus docetaxel following FEC as adjuvant chemotherapy in axillary node-positive early breast cancer: a multicenter randomized study of the Hellenic Oncology Research Group (HORG).

artículo científico publicado en 2014

Favorable clinical course of patients experiencing bevacizumab-induced proteinuria

artículo científico publicado en 2010

Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes

article

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

artículo científico publicado en 2020

Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

artículo científico publicado en 2021

Genetic Evidence for the Association between Schizophrenia and Breast Cancer.

artículo científico publicado en 2018

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

article

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

scientific article published on 18 May 2020

Genome-wide association study of germline variants and breast cancer-specific mortality

artículo científico publicado en 2019

Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

artículo científico publicado en 2020

Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type

artículo científico publicado en 2014

Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer

artículo científico publicado en 2018

Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis

artículo científico publicado en 2021

Global cancer control: responding to the growing burden, rising costs and inequalities in access.

artículo científico publicado en 2018

Haploinsufficiency for either one of the type-II regulatory subunits of protein kinase A improves the bone phenotype of Prkar1a+/- mice

artículo científico publicado en 2015

Hematopoietic neoplasms in Prkar2a-deficient mice

artículo científico publicado en 2015

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

artículo científico publicado en 2017

Incorporating progesterone receptor expression into the PREDICT breast prognostic model

artículo científico publicado en 2022

Is IGSF1 involved in human pituitary tumor formation?

artículo científico publicado en 2014

KCNJ5 mutations in the National Institutes of Health cohort of patients with primary hyperaldosteronism: an infrequent genetic cause of Conn's syndrome

artículo científico publicado en 2012

Large-cell calcifying Sertoli cell tumors of the testes in pediatrics

artículo científico publicado en 2012

Lung cancer in the era of Greek economic crisis

artículo científico publicado en 2014

Mendelian randomisation study of smoking exposure in relation to breast cancer risk

artículo científico publicado en 2021

Paclitaxel and docetaxel in the treatment of breast cancer

artículo científico publicado en 2008

Palliative chemotherapy for patients with breast cancer

artículo científico publicado en 2015

Pancreatic ductal and acinar cell neoplasms in Carney complex: a possible new association

artículo científico publicado en 2011

Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes

artículo científico publicado en 2022

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

artículo científico publicado en 2019

Potential Late Effect of Gonadotropin-Releasing Hormone Agonists in Combination With Chemotherapy for Early Breast Cancer

artículo científico publicado en 2012

Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?

artículo científico publicado en 2015

Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer

artículo científico publicado en 2011

Prkar1a gene knockout in the pancreas leads to neuroendocrine tumorigenesis

artículo científico publicado en 2016

Prophylactic and therapeutic strategies in chemotherapy-induced neutropenia.

artículo científico publicado en 2011

Proteinuria and favourable clinical response in a patient receiving paclitaxel + bevacizumab for metastatic breast cancer

scientific article published on 01 July 2010

Publisher Correction: Shared heritability and functional enrichment across six solid cancers

scientific article published on 23 September 2019

Rare germline copy number variants (CNVs) and breast cancer risk

artículo científico publicado en 2022

Salvage treatment in metastatic breast cancer with weekly paclitaxel and bevacizumab

artículo científico publicado en 2010

Screening and detection of breast cancer and prostate cancer.

artículo científico publicado en 2010

Sequential vs concurrent epirubicin and docetaxel as adjuvant chemotherapy for high-risk, node-negative, early breast cancer: an interim analysis of a randomised phase III study from the Hellenic Oncology Research Group

artículo científico publicado en 2017

Shared heritability and functional enrichment across six solid cancers

artículo científico publicado en 2019

Shared heritability and functional enrichment across six solid cancers

Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG).

artículo científico publicado en 2015

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

scientific article published on 01 November 2019

The cAMP pathway and the control of adrenocortical development and growth

artículo científico publicado en 2011

The care of adolescents and young adults with cancer: results of the ESMO/SIOPE survey. ⬇️

artículo científico publicado en 2017

The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type.

artículo científico publicado en 2016

Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

artículo científico publicado en 2020

Two truncating variants in FANCC and breast cancer risk

artículo científico publicado en 2019

Weekly Paclitaxel and Carboplatin Plus Bevacizumab as First-Line Treatment of Metastatic Triple-Negative Breast Cancer. A Multicenter Phase II Trial by the Hellenic Oncology Research Group

artículo científico publicado en 2017

Lista de obras de Emmanouil Saloustros

A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families

Advanced non-small-cell lung cancer in the elderly.

Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)

Anti-CV2 associated cerebellar degeneration after complete response to chemoradiation of head and neck carcinoma

Association analysis identifies 65 new breast cancer risk loci.

Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis

Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

Candidate DNA repair susceptibility genes identified by exome sequencing in high-risk pancreatic cancer

Care of adolescents and young adults with cancer in Asia: results of an ESMO/SIOPE/SIOP Asia survey

Case 17-2011: A Woman with a Mass in the Breast and Overlying Skin Changes

Celecoxib reduces glucocorticoids in vitro and in a mouse model with adrenocortical hyperplasia

Celecoxib treatment of fibrous dysplasia (FD) in a human FD cell line and FD-like lesions in mice with protein kinase A (PKA) defects

Common variants in breast cancer risk loci predispose to distinct tumor subtypes

Cytokeratin 19-positive circulating tumor cells in early breast cancer prognosis.

Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse.

Docetaxel in the treatment of advanced non-small-cell lung cancer.

Dose-dense paclitaxel versus docetaxel following FEC as adjuvant chemotherapy in axillary node-positive early breast cancer: a multicenter randomized study of the Hellenic Oncology Research Group (HORG).

Favorable clinical course of patients experiencing bevacizumab-induced proteinuria

Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

Genetic Evidence for the Association between Schizophrenia and Breast Cancer.

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

Genome-wide association study of germline variants and breast cancer-specific mortality

Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type

Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer

Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis

Global cancer control: responding to the growing burden, rising costs and inequalities in access.

Haploinsufficiency for either one of the type-II regulatory subunits of protein kinase A improves the bone phenotype of Prkar1a+/- mice

Hematopoietic neoplasms in Prkar2a-deficient mice

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Incorporating progesterone receptor expression into the PREDICT breast prognostic model

Is IGSF1 involved in human pituitary tumor formation?

KCNJ5 mutations in the National Institutes of Health cohort of patients with primary hyperaldosteronism: an infrequent genetic cause of Conn's syndrome

Large-cell calcifying Sertoli cell tumors of the testes in pediatrics

Lung cancer in the era of Greek economic crisis

Mendelian randomisation study of smoking exposure in relation to breast cancer risk

Paclitaxel and docetaxel in the treatment of breast cancer

Palliative chemotherapy for patients with breast cancer

Pancreatic ductal and acinar cell neoplasms in Carney complex: a possible new association

Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

Potential Late Effect of Gonadotropin-Releasing Hormone Agonists in Combination With Chemotherapy for Early Breast Cancer

Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?

Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer

Prkar1a gene knockout in the pancreas leads to neuroendocrine tumorigenesis

Prophylactic and therapeutic strategies in chemotherapy-induced neutropenia.

Proteinuria and favourable clinical response in a patient receiving paclitaxel + bevacizumab for metastatic breast cancer

Publisher Correction: Shared heritability and functional enrichment across six solid cancers

Rare germline copy number variants (CNVs) and breast cancer risk

Salvage treatment in metastatic breast cancer with weekly paclitaxel and bevacizumab

Screening and detection of breast cancer and prostate cancer.

Sequential vs concurrent epirubicin and docetaxel as adjuvant chemotherapy for high-risk, node-negative, early breast cancer: an interim analysis of a randomised phase III study from the Hellenic Oncology Research Group

Shared heritability and functional enrichment across six solid cancers

Shared heritability and functional enrichment across six solid cancers

Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG).

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

The cAMP pathway and the control of adrenocortical development and growth

The care of adolescents and young adults with cancer: results of the ESMO/SIOPE survey. ⬇️

The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type.

Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

Two truncating variants in FANCC and breast cancer risk

Weekly Paclitaxel and Carboplatin Plus Bevacizumab as First-Line Treatment of Metastatic Triple-Negative Breast Cancer. A Multicenter Phase II Trial by the Hellenic Oncology Research Group